{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:04:11Z","timestamp":1793419451683,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17140901001"],"award-info":[{"award-number":["17140901001"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18430760400"],"award-info":[{"award-number":["18430760400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17140901000"],"award-info":[{"award-number":["17140901000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773808"],"award-info":[{"award-number":["81773808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.apsb.2019.11.007","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:12:43Z","timestamp":1573737163000},"page":"850-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease"],"prefix":"10.1016","volume":"10","author":[{"given":"Xinrun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2019.11.007_bib1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/j.2040-4603.2014.tb00594.x","article-title":"Organic anion uptake by hepatocytes","volume":"4","author":"Wolkoff","year":"2014","journal-title":"Comp Physiol"},{"key":"10.1016\/j.apsb.2019.11.007_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.apsb.2019.11.007_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.007_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1208\/s12248-015-9740-x","article-title":"Role of organic anion-transporting polypeptides (OATPs) in cancer therapy","volume":"17","author":"Thakkar","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.apsb.2019.11.007_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1248\/bpb.b14-00767","article-title":"Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs","volume":"38","author":"Maeda","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.apsb.2019.11.007_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","article-title":"Organic anion-transporting polypeptides","volume":"73","author":"Stieger","year":"2014","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.apsb.2019.11.007_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/clpt.2012.127","article-title":"Contribution of the OATP1B subfamily to cancer biology and treatment","volume":"92","author":"Sissung","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2019.11.007_bib9","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug\u2013drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2019.11.007_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","article-title":"Clinical importance of OATP1B1 and OATP1B3 in drug\u2013drug interactions","volume":"26","author":"Shitara","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.apsb.2019.11.007_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter Consortium","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2019.11.007_bib12","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.apsb.2019.11.007_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2012.08.025","article-title":"Hereditary conjugated hyperbilirubinaemia: 37 years later","volume":"58","author":"Dhumeaux","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2019.11.007_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2019.11.007_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/pcan.2016.42","article-title":"Role of OATP transporters in steroid uptake by prostate cancer cells in\u00a0vivo","volume":"20","author":"Green","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.apsb.2019.11.007_bib16","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1158\/1078-0432.CCR-07-4118","article-title":"Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer","volume":"14","author":"Hamada","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2019.11.007_bib17","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1200\/JCO.2010.31.2405","article-title":"SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer","volume":"29","author":"Yang","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2019.11.007_bib18","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2019.11.007_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1517\/17425255.2015.1032245","article-title":"Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity","volume":"11","author":"Gonzalez","year":"2015","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.apsb.2019.11.007_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.apsb.2019.11.007_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfn038","article-title":"Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake\/toxicity of phalloidin and microcystin-LR","volume":"103","author":"Lu","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2019.11.007_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/mol.108.046458","article-title":"Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2\/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin","volume":"74","author":"Zaher","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pediatrneurol.2003.09.011","article-title":"Bilirubin toxicity in the developing nervous system","volume":"29","author":"Shapiro","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.apsb.2019.11.007_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.dmpk.2015.06.003","article-title":"Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans","volume":"30","author":"Mikkaichi","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.apsb.2019.11.007_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.007_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.007_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.apsb.2019.11.007_bib28","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bbamcr.2016.06.009","article-title":"Insert, remove or replace: a highly advanced genome editing system using CRISPR\/Cas9","volume":"1863","author":"Ceasar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2019.11.007_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.apsb.2017.01.002","article-title":"Application of CRISPR\/Cas9 in plant biology","volume":"7","author":"Liu","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.11.007_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.curtheres.2015.02.001","article-title":"Pharmacokinetic properties of single- and multiple-dose pitavastatin calcium tablets in healthy Chinese volunteers","volume":"77","author":"Luo","year":"2015","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.apsb.2019.11.007_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2019.11.007_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2016.251","article-title":"Loss of SLCO1B3 drives taxane resistance in prostate cancer","volume":"115","author":"de Morr\u00e9e","year":"2016","journal-title":"Br J Canc"},{"key":"10.1016\/j.apsb.2019.11.007_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.112.195750","article-title":"Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system","volume":"343","author":"Ulvestad","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2019.11.007_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.apsb.2019.03.005","article-title":"Role of vitamin D receptor in the regulation of CYP3A gene expression","volume":"9","author":"Qin","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2019.11.007_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1124\/dmd.110.032060","article-title":"Pharmacokinetic interaction between JBP485 and cephalexin in rats","volume":"38","author":"Zhang","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2019.11.007_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/dmd.118.084277","article-title":"Development and characterization of MDR1 (Mdr1a\/b) CRISPR\/Cas9 knockout rat model","volume":"47","author":"Liang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2019.11.007_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2017.07.013","article-title":"Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats","volume":"143","author":"Qin","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bcp.2016.03.001","article-title":"Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR\/Cas9","volume":"105","author":"Wang","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib39","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2019.11.007_bib40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12377","article-title":"Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin","volume":"78","author":"Prueksaritanont","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/GIM.0b013e318238b38c","article-title":"Personalizing medicine with clinical pharmacogenetics","volume":"13","author":"Scott","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.apsb.2019.11.007_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2133\/dmpk.DMPK-12-RV-099","article-title":"Impact of genetic variation in OATP transporters to drug disposition and response","volume":"28","author":"Gong","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.apsb.2019.11.007_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.01.018","article-title":"Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics","volume":"77","author":"Niemi","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2019.11.007_bib44","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/jac\/dkq324","article-title":"Impact of drug transporters on cellular resistance towards saquinavir and darunavir","volume":"65","author":"K\u00f6nig","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2019.11.007_bib45","doi-asserted-by":"crossref","first-page":"34617","DOI":"10.18632\/oncotarget.16119","article-title":"Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1","volume":"8","author":"Herraez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2019.11.007_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/bjc.2015.5","article-title":"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy","volume":"112","author":"Teft","year":"2015","journal-title":"Br J Canc"},{"key":"10.1016\/j.apsb.2019.11.007_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-10-1023","article-title":"Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes","volume":"20","author":"Wright","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.apsb.2019.11.007_bib48","doi-asserted-by":"crossref","first-page":"113612","DOI":"10.1016\/j.bcp.2019.08.014","article-title":"Organic anion transport polypeptide 1b2 selectively affects the pharmacokinetic interaction between paclitaxel and sorafenib in rats","volume":"169","author":"Ma","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.007_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1203\/PDR.0b013e31817d9be0","article-title":"A new animal model of hemolytic hyperbilirubinemia-induced bilirubin encephalopathy (kernicterus)","volume":"64","author":"Rice","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.apsb.2019.11.007_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1203\/00006450-200102000-00012","article-title":"Subcellular localization of bilirubin in rat brain after in\u00a0vivo i.v. administration of [3H]bilirubin","volume":"49","author":"Hansen","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.apsb.2019.11.007_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104816","article-title":"Generation of Ugt1-deficient murine liver cell lines using TALEN technology","volume":"9","author":"Porro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2019.11.007_bib52","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519309098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519309098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:15Z","timestamp":1761928995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383519309098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2211383519309098"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2019.11.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}